Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had ...

Lung cancer may be curable, depending on a number of factors, including your age, health, stage of cancer, and how it ...

Drs. Fatemeh Ardeshir-Larijani and Mohamed Abazeed discuss a validated AI model that can predict how patients with advanced ...

When non-small cell lung cancer (NSCLC) spreads beyond the lungs, it often metastasizes to the bones. Estimates suggest 20 to 30 percent of people with NSCLC have bone metastases at the time of ...

Even as federal health research budgets are being slashed, Duarte-based City of Hope has managed to win a grant of up to ...

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...

Anlotinib combined with immune checkpoint inhibitors may benefit patients with extensive-stage small cell lung cancer treated ...

The IMPACT-RCC study 7 evaluated visualization of clear cell RCC lesions in 42 patients with metastatic disease (n = 449 lesions). Patients in this study had a lesion size cutoff of 1 cm (lymph nodes ...

The firm is advancing its AI-driven multi-modal digital pathology platform as a tool for guiding clinical trial design and patient identification.